BUY Piramal Pharma Limited — Rakesh Bansal
byRakesh BansalHorizon: Swing (≤2wk)30 Jul 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
2 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·3 Aug · yesterday
3 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · same horizon·30 Jul · 5d ago
Q1 Results Highlights: Piramal Pharma Loss Narrows; Eicher Motors Profit Jumps Over 21%; Waaree Energies Revenue Soars 79%
NewsNdtv-Profit·29 Jul · 6d ago
Piramal Pharma Q1 Results: Net Loss Narrows As Margin Expands; Revenue Up 17%
NewsNdtv-Profit·29 Jul · 6d ago
Piramal Pharma Limited announced its Q1 FY27 financial results, reporting a 17% increase in revenue from operations and a 72% rise in EBITDA. The company highlighted strong performance across all thre
NSE · Press Release·29 Jul · 6d ago
Buy, Sell Or Hold: Mahindra & Mahindra, UltraTech Cement, Piramal Pharma, Groww And Swiggy — Ask Profit
NewsNdtv-Profit·30 Jul · 5d ago
Piramal Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
NSE · Outcome of Board Meeting·29 Jul · 6d ago
Piramal Pharma temporarily suspends Ahmedabad plant operations due to heavy rainfall
NewsCnbc-Tv18·25 Jul · 2w ago
Piramal Pharma, Authum Investment, Vaibhav Global Show Technical Breakouts
NewsGoogle News·20 Jul · 2w ago
HDFC Mutual Fund reduces stake in Piramal Pharma by 2.005%
NewsGoogle News·18 Jul · 2w ago
HDFC Mutual Fund Sells 2% Stake in Piramal Pharma
NewsGoogle News·17 Jul · 3w ago
HDFC Mutual Fund ने Piramal Pharma मधील हिस्सा विकला, मोठी घट!
NewsGoogle News·17 Jul · 3w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Piramal Pharma
- BUY — Nirav Chheda, Nirmal Bang Securities24 Sept 2026 · ~1 year · target ₹250 · Active
- BUY — Rakesh Bansal24 Sept 2026 · Same day · target ₹219 · SL hit
- BUY — Goldman Sachs24 Sept 2026 · ~1 year · target ₹250 · Active
- BUY — Sacchitanand Uttekar, Tradebulls Securities22 Sept 2026 · ~3 months · target ₹230 · SL hit
- BUY — Siddharth Rai Mangala21 Sept 2026 · ~2 weeks · target ₹230 · SL hit
More from Rakesh Bansal
- BUY Infosys21 Oct 2026 · ~2 weeks · target ₹1,222 · Active
- BUY Tech Mahindra21 Oct 2026 · ~2 weeks · target ₹1,890 · Active
- BUY Mastek21 Oct 2026 · ~2 weeks · target ₹1,940 · Active
- BUY L&T Technology Services21 Oct 2026 · Same day · target ₹4,230 · SL hit
- BUY GE Vernova T&D India21 Oct 2026 · ~2 weeks · target ₹4,030 · SL hit

